Nurse Practitioner, Family · Eastpointe, MI
NPI
1366633588
Since 2007
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
17200 E 10 Mile Rd
Eastpointe, MI, 48021
Phone (586) 859-7455
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$325K
3,932 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Barbara J Dalziel prescribed most often to Medicare patients was Naproxen, with 495 prescriptions and refills. In total Barbara J Dalziel wrote 3,932 Medicare prescriptions that cost $325K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Naproxen Generic | 495 | 495 | 107 | $5,375 |
| Oxycodone Hcl Generic | 398 | 398 | 92 | $9,901 |
| Naloxone Hcl Generic | 289 | 289 | 76 | $23K |
| Diclofenac Sodium Generic | 203 | 212 | 64 | $7,186 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 187 | 187 | 55 | $3,755 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 163 | 163 | 47 | $2,277 |
| Lisinopril Generic | 145 | 149 | 28 | $262 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 132 | 140 | 37 | $4,340 |
| Furosemide Generic | 128 | 130 | 29 | $215 |
| Ibuprofen Generic | 97 | 98 | 29 | $642 |
| Cyclobenzaprine Hcl Generic | 92 | 94 | 33 | $1,428 |
| Metformin Hcl Generic | 82 | 88 | 19 | $5,296 |
| Varenicline Tartrate Generic | 69 | 69 | 13 | $19K |
| Lidocaine Generic | 68 | 71 | 22 | $2,890 |
| Clindamycin Phosphate Generic | 62 | 62 | 14 | $1,319 |
Brand drugs: 242 claims; generic drugs: 3,679 claims; opioid claims: 748.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Barbara J Dalziel were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.